Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|September 1, 1995
Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulinD F Lazar, R J Wiese, M J Brady, et al.
Annals of Surgical Oncology|October 28, 2008
A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosisJohn C McAuliffe, Kelly K Hunt, Alexander J F Lazar, et al.
The American Journal of Surgical Pathology|September 18, 2012
MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangementLeona A Doyle, Wei-Lien Wang, Paola Dal Cin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 25, 2010
Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?Joshua Weaver, Priya Rao, John R Goldblum, et al.
Cancer|September 7, 2010
Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumorsAntti Ylipää, Kelly K Hunt, Jilong Yang, et al.
The American Journal of Pathology|October 4, 2008
Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumorsAlexander J F Lazar, Daniel Tuvin, Shohrae Hajibashi, et al.
The American Journal of Surgical Pathology|June 14, 2008
Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasiaRajenda S Singh, Wayne Grayson, Mark Redston, et al.
Cell Chemical Biology|October 20, 2023
Interrogating direct NLRP3 engagement and functional inflammasome inhibition using cellular assaysKelly A Teske, Cesear Corona, Jennifer Wilkinson, et al.
British Journal of Cancer|September 25, 2008
A novel AKT3 mutation in melanoma tumours and cell linesM A Davies, K Stemke-Hale, C Tellez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylateJohn C McAuliffe, Alexander J F Lazar, Dan Yang, et al.
Pageof 12